v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024   142,086      
Beginning balance at Dec. 31, 2024 $ 965,250 $ 3 $ 1,958,157 $ (100) $ (992,810)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of vested stock options (in shares)   317      
Vesting of restricted stock units 687   687    
Vesting of restricted stock units (in shares)   3,304      
Shares issued under bonus program (in shares)   951      
Shares issued under bonus program $ 6,898   6,898    
Shares issued under employee stock purchase program (in shares) 500 514      
Shares issued under employee stock purchase program $ 3,325   3,325    
Stock-based compensation 43,245   43,245    
Net loss (76,689)       (76,689)
Other comprehensive loss (69)     (69)  
Ending balance (in shares) at Jun. 30, 2025   147,172      
Ending balance at Jun. 30, 2025 942,647 $ 3 2,012,312 (169) (1,069,499)
Beginning balance (in shares) at Mar. 31, 2025   144,686      
Beginning balance at Mar. 31, 2025 957,023 $ 3 1,989,108 (130) (1,031,958)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of vested stock options (in shares)   149      
Vesting of restricted stock units $ 279   279    
Vesting of restricted stock units (in shares)   1,823      
Shares issued under employee stock purchase program (in shares) 500 514      
Shares issued under employee stock purchase program $ 3,325   3,325    
Stock-based compensation 19,600   19,600    
Net loss (37,541)       (37,541)
Other comprehensive loss (39)     (39)  
Ending balance (in shares) at Jun. 30, 2025   147,172      
Ending balance at Jun. 30, 2025 $ 942,647 $ 3 2,012,312 (169) (1,069,499)
Beginning balance (in shares) at Dec. 31, 2025 151,500 151,537      
Beginning balance at Dec. 31, 2025 $ 929,578 $ 3 2,044,103 (41) (1,114,487)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of vested stock options (in shares)   255      
Vesting of restricted stock units 1,135   1,135    
Vesting of restricted stock units (in shares)   4,605      
Shares issued under bonus program (in shares)   2,180      
Shares issued under bonus program $ 39,455   39,455    
Shares issued under employee stock purchase program (in shares) 500 497      
Shares issued under employee stock purchase program $ 4,609   4,609    
Stock-based compensation 52,607   52,607    
Net loss (36,115)       (36,115)
Other comprehensive loss $ (452)     (452)  
Ending balance (in shares) at Jun. 30, 2026 159,100 159,074      
Ending balance at Jun. 30, 2026 $ 990,817 $ 3 2,141,909 (493) (1,150,602)
Beginning balance (in shares) at Mar. 31, 2026   156,368      
Beginning balance at Mar. 31, 2026 977,146 $ 3 2,112,577 (423) (1,135,011)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of vested stock options (in shares)   31      
Vesting of restricted stock units $ 92   92    
Vesting of restricted stock units (in shares)   2,178      
Shares issued under employee stock purchase program (in shares) 500 497      
Shares issued under employee stock purchase program $ 4,609   4,609    
Stock-based compensation 24,631   24,631    
Net loss (15,591)       (15,591)
Other comprehensive loss $ (70)     (70)  
Ending balance (in shares) at Jun. 30, 2026 159,100 159,074      
Ending balance at Jun. 30, 2026 $ 990,817 $ 3 $ 2,141,909 $ (493) $ (1,150,602)